ArticleCancer immunology, immunotherapy : CII2018
Safety of shortened infusion times for combined ipilimumab and nivolumab.
Maximilian Gassenmaier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it